Sol Gel Technologies Ltd. (NASDAQ: SLGL) posted a second-quarter adjusted loss of $1.13 per share, exceeding expectations and marking a $2.20 improvement versus the $-3.33 forecast by analysts. Revenue totaled $591,000, less than half of the $1.2 million consensus estimate.
The company’s financial health remains under scrutiny despite the earnings beat. InvestingPro rated Sol Gel Technologies’ financial health as "great performance," though the revenue shortfall underscores ongoing challenges in scaling operations. Analysts had issued one positive earnings revision over the last 90 days, with no negative adjustments.
Shares of Sol Gel Technologies closed at $78.59 on Tuesday, up 2.4% over the past three months and 205% higher year-over-year. The stock’s performance reflects investor confidence in the company’s long-term prospects, even as near-term revenue growth lags behind forecasts.
